现代肿瘤医学
現代腫瘤醫學
현대종류의학
Journal of Modern Oncology
2015年
22期
3292-3295
,共4页
结直肠癌%总体生存率%无复发生存率%预后
結直腸癌%總體生存率%無複髮生存率%預後
결직장암%총체생존솔%무복발생존솔%예후
colorectal cancer%overall survival%recurrence -free survival%prognosis
目的:研究接头蛋白 DOK2在结直肠癌中的表达及其临床病理学意义。方法:免疫组化检测87例结直肠癌组织中 DOK2的表达,并对结直肠癌患者进行生存分析。结果:DOK2在63例(72%)结直肠癌组织中表达阴性,在正常组织中表达阳性。DOK2表达丢失与肿瘤分化程度(P =0.001)和复发(P =0.048)之间有显著相关性。COX 回归分析显示,DOK2表达丢失是结直肠癌患者总体生存率(overall survival,OS)(P =0.001)和无复发生存率(recurrence -free survival,RFS)(P =0.006)的独立影响因素。Kaplan -Meier 法生存分析表明,与 DOK2表达阳性的患者相比,DOK2表达阴性的患者中位生存时间显著缩短(46个月 vs 53个月,P <0.001),无复发中位生存时间也显著缩短(36个月 vs 49个月,P <0.001)。结论:接头蛋白 DOK2是结直肠癌患者预后的独立影响因素。
目的:研究接頭蛋白 DOK2在結直腸癌中的錶達及其臨床病理學意義。方法:免疫組化檢測87例結直腸癌組織中 DOK2的錶達,併對結直腸癌患者進行生存分析。結果:DOK2在63例(72%)結直腸癌組織中錶達陰性,在正常組織中錶達暘性。DOK2錶達丟失與腫瘤分化程度(P =0.001)和複髮(P =0.048)之間有顯著相關性。COX 迴歸分析顯示,DOK2錶達丟失是結直腸癌患者總體生存率(overall survival,OS)(P =0.001)和無複髮生存率(recurrence -free survival,RFS)(P =0.006)的獨立影響因素。Kaplan -Meier 法生存分析錶明,與 DOK2錶達暘性的患者相比,DOK2錶達陰性的患者中位生存時間顯著縮短(46箇月 vs 53箇月,P <0.001),無複髮中位生存時間也顯著縮短(36箇月 vs 49箇月,P <0.001)。結論:接頭蛋白 DOK2是結直腸癌患者預後的獨立影響因素。
목적:연구접두단백 DOK2재결직장암중적표체급기림상병이학의의。방법:면역조화검측87례결직장암조직중 DOK2적표체,병대결직장암환자진행생존분석。결과:DOK2재63례(72%)결직장암조직중표체음성,재정상조직중표체양성。DOK2표체주실여종류분화정도(P =0.001)화복발(P =0.048)지간유현저상관성。COX 회귀분석현시,DOK2표체주실시결직장암환자총체생존솔(overall survival,OS)(P =0.001)화무복발생존솔(recurrence -free survival,RFS)(P =0.006)적독립영향인소。Kaplan -Meier 법생존분석표명,여 DOK2표체양성적환자상비,DOK2표체음성적환자중위생존시간현저축단(46개월 vs 53개월,P <0.001),무복발중위생존시간야현저축단(36개월 vs 49개월,P <0.001)。결론:접두단백 DOK2시결직장암환자예후적독립영향인소。
Objective:To investigate the clinicopathological significance of DOK2 expression in colorectal cancer. Methods:Expression of adaptor protein DOK2 was detected immuno -histochemically.And the survival of the color-ectal cancer patients was analysed.Results:Loss of DOK2 expression was detected in 67 tissue samples (72%)of colorectal cancer.Meanwhile DOK2 was positively detected in normal tissue.Loss of DOK2 expression was significant-ly related with tumor differentiation (P =0.001)and tumor recurrence (P =0.048).COX regression analysis indica-ted that loss of DOK2 expression was independent predictor of overall survival (OS)(P =0.001)and recurrence -free survival (RFS)(P =0.006).Kaplan -Meier survival analysis showed that,compared with patients with positive expression of DOK2,patients with loss of DOK2 expression had a shortened median survival time (46 months vs 53 months,P <0.001)and shortened recurrence -free survival time (36 months vs 49 months,P <0.001).Conclu-sion:Loss of DOK2 expression is an independent prognostic factor in patients with colorectal cancer.